Last reviewed · How we verify

Injection of Lidocaine into Foot

Brown University · Phase 1 active Small molecule Quality 13/100

Injection of Lidocaine into Foot is a Small molecule drug developed by Brown University. It is currently in Phase 1 development.

At a glance

Generic nameInjection of Lidocaine into Foot
SponsorBrown University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Injection of Lidocaine into Foot

What is Injection of Lidocaine into Foot?

Injection of Lidocaine into Foot is a Small molecule drug developed by Brown University.

Who makes Injection of Lidocaine into Foot?

Injection of Lidocaine into Foot is developed by Brown University (see full Brown University pipeline at /company/brown-university).

What development phase is Injection of Lidocaine into Foot in?

Injection of Lidocaine into Foot is in Phase 1.

What are the side effects of Injection of Lidocaine into Foot?

Common side effects of Injection of Lidocaine into Foot include Oedema, Pain, Dysaesthesia, Contusion, Injection site pain, Injection site swelling.

Related